We are a biotechnology company with focus on tissue and muscle injury. Injuries to muscle such as back pain or ligaments and vascular injuries such as sclerosis are often permanent and carry significant socioeconomic consequences. About 10 million people in the United States suffer from back muscle injuries that have become a chronic back pain. Another 2-3 million suffer from sport related injuries, ligaments stretched, spasm etc. These conditions carries a life time pain, that can not be resolved by normal and usual pain killers. Pain and suffering from these injuries are due to the constant release of chemical mediators, known as cytokines. We have discovered molecules, known as growth factors that prevent the effect of these cytokines and associated pain by preventing further damage to the tissue and rebuilding the damaged tissues.
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM